this for topics. the Thanks Today, for Thanks will review we for earnings cover call. QX. We'll our following us achievements afternoon for major QX joining our Matt.
exit activities portfolio. update an in We will the provide on
companies. on will raises We portfolio provide by capital our an update
highlights each QX We will for company. share
statistics allowed take safeguard to I'll September. to will financial million, $XX trading sale a for strategic on August, our achievements deployments through commentary listed million up upsize and these able to Mark on which us with we'll had on a in quarter provide $X publicly per strategy to hold the We've its it company stock maximize an expected We third that today. in approximately delivered to the we'll share back then buy capital notable viewed We comparable the which $X in follow completed we tender with provided you and outstanding as were XX% launch portfolio open start our continue XXXX. will We for to QX at Safeguard ourselves delivered shareholders. in of tender for to self and some quarter liquidity us Q&A. achievements. $XX review share. $XX price view our two a to our cash and return accretive a proceeds million with our to Flashtalking to repurchase of productive tender shares which value balance
and interests strategy. portfolio consistent remaining our about with excited are We our
This shareholders to with based on portfolio. a we continue We operating target the shareholders. exit next that the requirements, target it million capital developments I sheet exits, to our remind follow-on costs, our of expectations threshold Note and threshold to so up is To time in balance subject companies range to to deployment return based our buybacks could of will find down. horizons. cash adjustments $XX shareholders future our via $XX change as and million on have the exit move activities or with return is companies above and work established look we to our which to cash Safeguard's would dividends.
just has had call in varying update a earnings its QX to is was and company buyer. along process, strategic one an company from August, an launch launched third launched an degrees that The LoI positive signed we one September, process was The a our the disclosure M&A During in that M&A in discussions. of moves company now planning August, strategic August company This is process as with quickly in process follows. which sign. that shared
While should a now this we and result close. the we LoI in that purchase agreement, are are not transaction optimistic will certain that cautiously sign sale
are risks the be there would the return would its transaction. sale to harder October we and that launch involved predict. any September its Although range that of delayed until is specific the specific proceeds in And company If was time, The timing evaluate complete timing to in meaningful always completed, planning the course, to deals at a options order process capital to QX. shareholders. of of launch mid and
XXXX prospective events. soon deal, Our a should of assess is reach currently to buyers a but be It is would come underway. probability too the together, we it to believe one
value. the to were to the to did aggregate company if varying amount this and signed an meaningful On and to close, be discussions, a of closing. diligence. is chances deal fair in degrees through a proceeds it third recently difficult of our deal working Safeguard is in that complexity would There was relative this handicap terms its strategic The fair portfolio is transaction, of LoI not current market
cannot said with upside to this company as August, the a in addition merger to we be this If be and deal Having early finish said deal. In of it we deal believe a fourth this there that cash company, probability to close, an Safeguard not The would interest plan. line. that, part and stock equity at of a to stage the merger discussions is we be preferred companies standalone private combined company. for of retain in to handicap are another our the were combined engaged could getting the company's early meaning in what discussions stock the would Safeguard superior would
develop. they updates as you further We will provide
on Safeguard and deployed the capital notes and of growth transaction, in operations raise million equity shareholders that round other Trice this fund into converted existing the an choice investor Bioventus round. the closed touch part and X.X raises. strategic of capital as Safeguard its ton quarter transaction. A their and now equity with to portfolio Let's past
was which Three to was led $X we in be would portfolio be Also, into transactions. their growth as these companies For have XXXX. support of other raises. in raises primary is that the million, expect whether this Bioventus to Safeguard, capital participating we determine the capital these converted now, to deployed It to round. QX begun Safeguard in too soon explore
financings. expect exit partial an or we for part safeguard not So opportunity as exit of would these
of capital raises that occur. any course, will assurance Of these there's no
one publicly Bright to as in of of of QX these a one will Safeguard's Health healthcare exit companies, a we one apply this on comprehensive is the ad million highlights MediaMath, specific recap one position Note quick bullet portfolio traded private in portfolio we've company done with seven Moving on share Lumesis X.X Clutch consists Flashtalking quarters, highlights name. minority each to in each company, tech of and group, assessment marketing stakes tech and not provide our risks past company company fintech of portfolio companies. that each
its mentioned, double a growth with them NCR and as collaboration and closed sites Pfizer data meet significant led to Mayo digit on XXXX. sign on revenue in patients. by its on booking QX was for strategic is to is with was quarter its Trice Moxe up to had is meQuilibrium executing into track largest and which world up round distribution Clutch agreement exceed equity EBITDA traction goals. revenue its a positive provider on early a international Bioventus new largest million experiencing experiencing is InfoBionic publicly record is traded growth is is we products. and over XX% or robust QX, accelerated growth. an year-on-year. which continued and XXXX Trice's support Clinic saw of health with expand real the deployments. agreement Aktana, ever. continues XXX on data rollouts steady research hospitality represented anonymized plan to For with Lumesis XXXX a in marketplace, entered data Merck. with Prognose for QX Syapse saw number early marketplace integrations partnering
For their December. they hear a its progress XX Note all forward to expires Health enabled clients insurer. lockup health looking November and earnings their to platform on new its expanding out tech in about identity MediaMath IPO as QX released in late momentum continue we're integrated Bright our to group, vertically to that package. build solutions their strong more product experience
our market expect represent total assessment our value nor stock and note the of calculation values. part However, determination total our to and was material value we we be price a that it want has exit fair portfolio MediaMath material does meaningful tender to impact the no portfolio. that on was Safeguard ourselves upside this that do of note factored buy an components $X not a increase Also into of potential of the to or exit of our back
So our their are on plans on meaningful excited toward to companies good making executing about shareholders. their prospects progress we're to and value business Safeguard balance, return
relevant to statistics. publicly trading comparable listed share Next, we'd like
valuation As metrics part we our traded we've done quantitatively We we methodology I'll as track to in start and revenue on track stats companies qualitatively enterprise we that as publicly both as internal certain to as follow. of portfolio. well against growth company quarters, prior of revenue metrics the industry these forward provide use two important look comparable with as revenue end projected following as multiples. at of and the multiples We are October. developments. value most our The
to and and X.X August the turns For X.X healthcare publicly median comps call. traded and XXXX turns respectively multiples times XXXX down on enterprise from were our times X.XX respectively earnings X.X revenue value
XXXX turns the August traded from revenue publicly X.XX turns X.X to XXXX, respectively on call. value enterprise were times adtech down and comps our X.X in respectively X.XX For times median adtech and multiples
times times down traded revenue median publicly comps enterprise August. X.X marketing XXXX the value were turns from X.X multiples and X.XX For and tech XXXX on respectively,
expectations. to revenue Now I will growth turn
growth For consensus XX% for was publicly XXXX. healthcare XXXX the comps analyst XX% for and for revenue median traded
median analysts’ For comps, XXXX revenue publicly XX% for was for for the and growth XXXX. XX% traded adtech consensus
revenue For XX% publicly for XXXX. consensus traded for and for marketing XXXX, analysts’ tech comps, median was the XX% growth
that the and revenue aggregate XX% comparison growth some Bright Safeguard's lower. higher is For Health some experiencing projected is although over excluding rate rate, growth for portfolio XXXX, every not company purposes, for
balance comment I Lastly, for the want on follow year. on to the deployments of
deployed don't year-to-date $X.X including the $X.X release, in our the expect in to $X and million read balance in we've QX. in further you year. QX in million Trice portfolio, the Aktana portfolio million the for press in deployments of As We
We $X a will better As guidance than $X come meaningfully million to million million, over in to point to budgeted in the or deployments companies planned. XXXX which $X of XXXX. will these compares million to if million in $X.X our had CFO so reference, two I we QX, it Herndon. our $X At occur additional in time of would were Mark hand this happen to